Moreover, in tumor cells, loss of NEFH by promoter methylation leads to increased aerobic glycolysis and mitochondrial dysfunction [43] and could, therefore, contribute to the metabolic shift that is observed in aggressive ccRCC [44]. This evidence concerns the gene NEFH and nonpapillary renal cell carcinoma.